1. Home
  2. DUKR vs GNTA Comparison

DUKR vs GNTA Comparison

Compare DUKR & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DUKR

DUKE Robotics Corp. Common Stock

N/A

Current Price

$5.50

Market Cap

20.1M

Sector

Industrials

ML Signal

N/A

Logo Genenta Science S.p.A.

GNTA

Genenta Science S.p.A.

HOLD

Current Price

$1.50

Market Cap

19.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DUKR
GNTA
Founded
N/A
2014
Country
Israel
Italy
Employees
N/A
13
Industry
Aerospace
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.1M
19.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DUKR
GNTA
Price
$5.50
$1.50
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
33.9K
166.1K
Earning Date
N/A
03-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.75
$0.55
52 Week High
$7.41
$10.00

Technical Indicators

Market Signals
Indicator
DUKR
GNTA
Relative Strength Index (RSI) 33.83 44.74
Support Level $5.02 $1.31
Resistance Level $5.80 $1.70
Average True Range (ATR) 0.76 0.14
MACD -0.02 -0.07
Stochastic Oscillator 28.57 0.00

Price Performance

Historical Comparison
DUKR
GNTA

About GNTA Genenta Science S.p.A.

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Share on Social Networks: